Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity. - Wikidata - awgldk - TriplyDB

Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity.

Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity.

http://www.wikidata.org/entity/Q35064255

about

Antibodies as Mediators of Brain Pathology A model for lupus brain disease Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens An innovative method to identify autoantigens expressed on the endothelial cell surface: serological identification system for autoantigens using a retroviral vector and flow cytometry (SARF)Anti-Double-Stranded DNA IgG Participates in Renal Fibrosis through Suppressing the Suppressor of Cytokine Signaling 1 Signals.A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus.The inhibition of anti-DNA binding to DNA by nucleic acid binding polymers.Peptides and peptidomimetics as immunomodulators.Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration.Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy.Discovery of biomarkers for systemic lupus erythematosus using a library of synthetic autoantigen surrogates.Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc).Brain-reactive antibodies and disease.Maternal Anti-Fetal Brain IgG Autoantibodies and Autism Spectrum Disorder: Current Knowledge and its Implications for Potential Therapeutics Maternal antibodies and developing blood-brain barrier.Taming lupus-a new understanding of pathogenesis is leading to clinical advances.Integrative neuroscience approach to neuropsychiatric lupus Dopamine-2 receptor extracellular N-terminus regulates receptor surface availability and is the target of human pathogenic antibodies from children with movement and psychiatric disorders.Therapeutics to block autoantibody initiation and propagation in systemic lupus erythematosus and rheumatoid arthritis.The Functional and Molecular Properties, Physiological Functions, and Pathophysiological Roles of GluN2A in the Central Nervous System.Towards drug repositioning: a unified computational framework for integrating multiple aspects of drug similarity and disease similarity.Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA Antibodies Targeted silencing of DNA-specific B cells combined with partial plasma cell depletion displays additive effects on delaying disease onset in lupus-prone mice.Molecular property diagnostic suite (MPDS): Development of disease-specific open source web portals for drug discovery.β-Hydroxy-tetrahydroquinolines from Quinolines Using Chloroborane: Synthesis of the Peptidomimetic FISLE-412.Neuropsychiatric SLE: from animal model to human.Molecular and Functional Neuroscience in Immunity.

P2860

Q26780374-6ECD3546-E0F9-4EAE-981E-A175DF86BD24 Q26824461-DE232687-FC1A-41D8-99EB-A2C2F1DC3BE7 Q28075974-E9FAA743-D6C1-4468-BE20-99CEC7B84F8A Q28386635-F7F48806-1C51-4593-8DF2-B554A68F7058 Q31110787-2D9A6B3D-7271-4F76-B8E5-FAEBC28635B9 Q33740586-E184BC4F-37ED-41D4-8954-980268C3D43F Q34322432-D818065F-52EE-4449-85F5-3560B45A711A Q34342476-D3C8AAC6-2821-4339-AD61-4969E975C935 Q34359984-A101216C-CFDA-4085-9CD2-1FA00CCD6117 Q34463760-BAEFE5E1-CDC9-4752-B68E-563ADD1BF4ED Q34654491-F89BF9AD-7FE3-4150-BFA2-483A6B11C714 Q35051889-50FB2DE1-B9D9-4302-AB2E-24953DCD9EF6 Q35175458-EF0FFB4F-BA47-49F5-82CD-F74C395E59BB Q35236365-C8D9789B-64FC-4CF3-9C30-FC1B3ED4EFE1 Q35458567-86C2C9A9-C49A-42FA-948D-B32DF9BD4251 Q36161935-45CDFE68-C661-40AA-AF5B-D77EE3E05029 Q36556849-DE6551AF-D1DD-40EC-BB34-56BF9A5056B5 Q36712941-4169A617-1A7F-41A1-848C-8C7C420645DB Q37032127-D370E970-310B-4D31-815A-22AC1A08A098 Q37466551-809B2307-67B4-495A-9DA7-0789833B69F0 Q38391522-BEDCDD2A-3B62-4313-964C-133794EB52F3 Q38707263-8B9ED823-9373-4A77-B1F9-19EE2CA378A0 Q40272650-B4EF648C-D987-4C67-BE06-71A402196D34 Q41406224-F4E53CCA-40C9-4EF3-86C6-678EDC1068AF Q46797870-43983B71-12A3-4021-BFE5-04B4DF5470F5 Q47366650-E801838E-68F1-457B-802C-FBB10295FBD7 Q48238490-492CF226-04CF-4CF8-9FAF-350C3A0E2121 Q51065096-0D5DAD47-C988-433D-885A-FD093FA1114A Q52574293-853A35F0-A956-4076-AE3C-EFE2211F652E

P2860

Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity.

http://www.wikidata.org/entity/Q35064255

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Generation of a unique small m ...... s lupus autoantibody activity.

@ast

Generation of a unique small m ...... s lupus autoantibody activity.

@en

type

label

Generation of a unique small m ...... s lupus autoantibody activity.

@ast

Generation of a unique small m ...... s lupus autoantibody activity.

@en

prefLabel

Generation of a unique small m ...... s lupus autoantibody activity.

@ast

Generation of a unique small m ...... s lupus autoantibody activity.

@en

P1433

Q35064255-82B7C3FF-A210-478A-A5C3-C480417D187F

P1476

Q35064255-E54E74B2-66D0-46E6-AAC1-B8A59FBE36D1

P2093

Q35064255-2F8D8849-0B9B-47DC-B40F-8F1A81D695B7

Q35064255-7B07B2D6-C56D-4F5E-B354-287FBF45093A

Q35064255-98659836-9DBC-4173-A960-867BFA333E4E

Q35064255-A87956A0-B69A-42F7-9FEC-798B1E5A6C9D

Q35064255-C76DB6DC-B05A-492D-88C8-498AE20B06B1

Q35064255-CA704CAB-4A73-4423-A339-5B9C470EEEEB

Q35064255-E9F6C570-DE46-4F93-9911-C72B4FB5D15D

P2860

Q35064255-04755E07-D998-45CE-8C1A-DE4651B7F662

Q35064255-092111CB-715B-4DDE-81A5-441952F93546

Q35064255-0C6A91A4-CD01-4A3F-87E3-E7668C764F93

Q35064255-0F6F83B0-D639-4E25-8C8E-17CCA3826485

Q35064255-104DF0C4-9ABC-431B-A0D6-351DD7C7C642

Q35064255-1F5818F4-51B5-4474-A12F-700D9ACAEE7E

Q35064255-2912801C-B773-473D-B5ED-18B7D774A144

Q35064255-2FF5FD92-3052-4509-B770-FC0018EBBEBC

Q35064255-3085A6B1-3A93-4FCD-AE96-0A0C945B03BF

Q35064255-394CB34B-F81E-4B5D-8923-8BF092A8775C

P304

Q35064255-120B5B46-C028-4673-BDA7-F4D188926569

P31

Q35064255-B89920B1-5752-4F91-96E4-3F55A532DF8F

P356

Q35064255-0A3B4CC8-3209-451C-9265-FB8BCE3498A1

P407

Q35064255-732C7AA4-C8A4-41E5-A4A1-3B3F9562095D

P433

Q35064255-2C9D7B09-65DC-4F0A-9B46-9911ED86FC5E

P478

Q35064255-EB2A3CF5-3DC8-4BF5-8D1A-39042EB6AA20

P577

Q35064255-954122A7-25E8-47DC-B054-C7FD95FB0560

P5875

Q35064255-0919A6EB-122C-4ED8-9629-842F8B4F745E

P698

Q35064255-1FFADDB7-C60B-42A6-A067-7A3F92F61E88

P921

Q35064255-68155BBA-325F-4C8D-887A-3F0F6F43D9B2

P932

Q35064255-3E2170DB-1AAF-4F06-ADAA-7C3B5847E4B2

P356

PNAS.1103555108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Generation of a unique small m ...... s lupus autoantibody activity.

@en

P2093

Angelos Papatheodorou

http://www.w3.org/2001/XMLSchema#string

Betty Diamond

http://www.w3.org/2001/XMLSchema#string

Bruce T Volpe

http://www.w3.org/2001/XMLSchema#string

Kai Fan Cheng

http://www.w3.org/2001/XMLSchema#string

Mingzhu He

http://www.w3.org/2001/XMLSchema#string

Ona Bloom

http://www.w3.org/2001/XMLSchema#string

Yousef Al-Abed

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice

Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis.

Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.

Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus.

Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.

Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.

Immunity and behavior: antibodies alter emotion

Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms.

Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus

P304

10255-10259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1103555108

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51196694

http://www.w3.org/2001/XMLSchema#string

P698

21646518

http://www.w3.org/2001/XMLSchema#string

P921

P932

3121823

http://www.w3.org/2001/XMLSchema#string